PRLog Home
All Businesses
All Newsrooms
Press Releases Home
Novadiol, Inc.
About
Newsroom
Contact
Filter By Industry
Select One
Biotech
Investment
Medical
Filter By Tag
Select One
Biotech Investments
Chronic Kidney Disease
Ckd
Nephrologists
Renal Disease
Secondary Hyperparathyroidism
SHPT
Venture Capital
Newsroom
Novadiol, Inc. Press releases
1 - 1 of 1 Press Release
Investigational New Drug Application Filed by Kansas City Firm
Jan 11, 2016
Novadiol Inc. seeks FDA approval for drug that will treat secondary hyperparathyroidism (shpt) in Stage 3 and Stage 4 chronic kidney disease (CKD) patients
Novadiol, Inc. RSS Feed
Share This Page
Website